Cabaletta Bio Inc
(NASDAQ:CABA)
$15.63
0[0.00%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
$15.63
0[0.00%]
After-Hours
PerksBuyCompare Brokers
Open-Close-
Vol / Avg.0 / 1.117MMkt Cap669.736M
Day Range- - -52 Wk Range4.430 - 19.340

Cabaletta Bio Stock (NASDAQ:CABA), Quotes and News Summary

Cabaletta Bio Stock (NASDAQ: CABA) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.0 / 1.117MMkt Cap669.736M
Day Range- - -52 Wk Range4.430 - 19.340
Lisa Levin - Nov 29, 2023, 5:48AM
Lisa Levin - Nov 28, 2023, 2:57PM
Lisa Levin - Nov 28, 2023, 2:44PM
Lisa Levin - Sep 18, 2023, 1:25PM
Lisa Levin - Sep 5, 2023, 1:34PM
Lisa Levin - Sep 5, 2023, 10:43AM
Vandana Singh - Jul 18, 2023, 2:27PM
Lisa Levin - Jun 21, 2023, 8:10AM
Lisa Levin - Jun 21, 2023, 6:39AM
Lisa Levin - May 16, 2023, 1:13PM
Globe Newswire - Nov 28, 2023, 4:30PM
Globe Newswire - Nov 9, 2023, 7:00AM
Business Wire - Nov 6, 2023, 8:15AM
Globe Newswire - Nov 6, 2023, 7:00AM
Globe Newswire - Oct 30, 2023, 8:00AM
Globe Newswire - Oct 2, 2023, 7:00AM
PRNewswire - Sep 25, 2023, 9:31AM
Globe Newswire - Sep 19, 2023, 8:00AM
Globe Newswire - Aug 30, 2023, 8:00AM
Globe Newswire - Aug 22, 2023, 8:00AM
Full archive of press releases available on Benzinga Pro
InvestorsObserver - 1 day ago
InvestorsObserver - 5 days ago
InvestorsObserver - Nov 29, 2023, 5:51AM
InvestorsObserver - Nov 28, 2023, 1:27PM
InvestorsObserver - Nov 28, 2023, 10:50AM
InvestorsObserver - Nov 27, 2023, 10:24AM
InvestorsObserver - Nov 22, 2023, 10:37AM
InvestorsObserver - Nov 20, 2023, 11:25AM
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS-0.400-0.370 0.0300
REV0
Q2 2023Est.ActualSurprise
EPS-0.440-0.370 0.0700
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-11-29Morgan StanleyMichael UlzMaintainsOverweightOverweightLowers28.0025.00
2023-11-29HC Wainwright & Co.Douglas TsaoReiteratesBuyBuyMaintains-25.00
2023-11-15Cantor FitzgeraldJoshua SchimmerMaintainsOverweightOverweightRaises40.0050.00
2023-11-10HC Wainwright & Co.Douglas TsaoMaintainsBuyBuyRaises17.0025.00

Related Companies

TickerCompanyChg %Mkt Cap
CABACabaletta Bio0%669.7M
ETNB89bio0.4%756.4M
RNAAvidity Biosciences0.65%615.2M
FDMT4D Molecular Therapeutics0%580.2M
AMAMAmbrx Biopharma0%764.1M
Q

How do I buy Cabaletta Bio (CABA) stock?

A

You can purchase shares of Cabaletta Bio (NASDAQ: CABA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cabaletta Bio's (CABA) competitors?

A

Other companies in Cabaletta Bio’s space includes: 89bio (NASDAQ:ETNB), Avidity Biosciences (NASDAQ:RNA), 4D Molecular Therapeutics (NASDAQ:FDMT), Ambrx Biopharma (NASDAQ:AMAM) and Cogent Biosciences (NASDAQ:COGT).

Q

What is the target price for Cabaletta Bio (CABA) stock?

A

The latest price target for Cabaletta Bio (NASDAQ: CABA) was reported by Morgan Stanley on Wednesday, November 29, 2023. The analyst firm set a price target for 25.00 expecting CABA to rise to within 12 months (a possible 59.95% upside). 24 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cabaletta Bio (CABA)?

A

The stock price for Cabaletta Bio (NASDAQ: CABA) is $15.63 last updated December 5, 2023 at 9:00 PM UTC.

Q

Does Cabaletta Bio (CABA) pay a dividend?

A

There is no dividend information for Cabaletta Bio.

Q

When is Cabaletta Bio (NASDAQ:CABA) reporting earnings?

A

Cabaletta Bio’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is Cabaletta Bio (CABA) going to split?

A

There is no upcoming split for Cabaletta Bio.

Q

What sector and industry does Cabaletta Bio (CABA) operate in?

A

Cabaletta Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.